Headquartered in Chandigarh, India, Ind-Swift Laboratories Ltd today is a global manufacturer of APIs, Intermediates and formulations (through group collaboration). With regulated 6+ manufacturing sites in Punjab and Jammu, we cater to the API needs of regulated markets including USFDA, EDQM, PMDA, ANVISA, EU-GMP, KFDA, and NMO, ANSM, Cofepris, TGA, WHO, ROW.
Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally.
Our core strength and competitive advantage lies in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood- related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets & they are the domestic leader in three biologics. We are leading creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trials.